Patents by Inventor Mai Murata

Mai Murata has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11825856
    Abstract: Provided is a composition for preventing or ameliorating a functional gastrointestinal disorder whose active ingredient is Bifidobacterium breve MCC1274 (FERM BP-11175). A composition for preventing or ameliorating a functional gastrointestinal disorder in the present technology can prevent or improve constipation or frequent bowel movements, regulate the number of bowel movements, improve stool quality, prevent or improve constipation, prevent or ameliorate bloating, or prevent or improve abdominal discomfort. Disclosed is a composition for preventing or ameliorating a functional gastrointestinal disorder accompanied by anxiety disorder. A composition for preventing or ameliorating a functional gastrointestinal disorder in the present technology can be used in a pharmaceutical composition or in a food or beverage composition.
    Type: Grant
    Filed: March 12, 2019
    Date of Patent: November 28, 2023
    Assignee: Morinaga Milk Industry Co., Ltd.
    Inventors: Mai Murata, Junichi Minami, Hazuki Maehata
  • Patent number: 11730171
    Abstract: Provided is a composition that may be used for a specific use application, such as a composition for enhancing a breast milk component. A composition containing a bacterium of the genus Bifidobacterium as an active ingredient is described.
    Type: Grant
    Filed: March 25, 2019
    Date of Patent: August 22, 2023
    Assignee: Morinaga Milk Industry Co., Ltd.
    Inventors: Hirohisa Izumi, Tatsuya Ehara, Akari Hiraku, Mai Murata, Noriyuki Iwabuchi
  • Publication number: 20220241354
    Abstract: An object of the present invention is to provide a technique for further promoting growth of bacteria belonging to the genus Bifidobacterium. By combining lactoferrin and/or lactoferrin hydrolyzate, and human milk oligosaccharides, a synergistic growth promoting effect of the bacteria belonging to the genus Bifidobacterium is achieved. Preferably, the human milk oligosaccharides include one or more selected from the group consisting of 2?-fucosyllactose, 3-fucosyllactose, and lactodifucotetraose. In addition, preferably, the bacteria belonging to the genus Bifidobacterium include one or more selected from the group consisting of Bifidobacterium breve, Bifidobacterium infantis, and Bifidobacterium longum.
    Type: Application
    Filed: June 5, 2020
    Publication date: August 4, 2022
    Applicant: MORINAGA MILK INDUSTRY CO., LTD.
    Inventors: Shutaro Kubo, Mai Murata, Hirotsugu Oda
  • Patent number: 11324784
    Abstract: Provided is a novel sleep-promoting composition. Provided is a sleep-promoting composition comprising bacteria belonging to Bifidobacterium breve as an active ingredient. The sleep-promoting composition related to the present technology may prolong a sleep time by prolonging non-REM sleep and REM sleep, reducing a spontaneous behavior amount during sleep, or reducing an awakening time during sleep. The sleep-promoting composition related to the present technology may also reduce difficulty in daytime awakening. The sleep-promoting composition related to the present technology may be used for a medical composition or a food and beverage composition.
    Type: Grant
    Filed: March 22, 2019
    Date of Patent: May 10, 2022
    Assignee: MORINAGA MILK INDUSTRY CO., LTD.
    Inventors: Mai Murata, Junichi Minami, Akio Yamada, Tetsuya Kuhara
  • Patent number: 11045508
    Abstract: Provided is a composition for preventing or improving impaired renal function, containing Bifidobacterium breve as an active ingredient. The composition for preventing or improving impaired renal function is capable of reducing blood creatinine levels. The composition for preventing or improving impaired renal function can also be used in a pharmaceutical composition or a food or beverage product composition.
    Type: Grant
    Filed: April 25, 2019
    Date of Patent: June 29, 2021
    Assignee: Morinaga Milk Industry Co., Ltd.
    Inventors: Mai Murata, Junichi Minami
  • Publication number: 20210106017
    Abstract: Provided is a composition that may be used for a specific use application, such as a composition for enhancing a breast milk component. A composition containing a bacterium of the genus Bifidobacterium as an active ingredient is described.
    Type: Application
    Filed: March 25, 2019
    Publication date: April 15, 2021
    Applicant: MORINAGA MILK INDUSTRY CO., LTD.
    Inventors: Hirohisa Izumi, Tatsuya Ehara, Akari Hiraku, Mai Murata, Noriyuki Iwabuchi
  • Publication number: 20210077548
    Abstract: Provided is a novel sleep-promoting composition. Provided is a sleep-promoting composition comprising bacteria belonging to Bifidobacterium breve as an active ingredient. The sleep-promoting composition related to the present technology may prolong a sleep time by prolonging non-REM sleep and REM sleep, reducing a spontaneous behavior amount during sleep, or reducing an awakening time during sleep. The sleep-promoting composition related to the present technology may also reduce difficulty in daytime awakening. The sleep-promoting composition related to the present technology may be used for a medical composition or a food and beverage composition.
    Type: Application
    Filed: March 22, 2019
    Publication date: March 18, 2021
    Applicant: MORINAGA MILK INDUSTRY CO., LTD.
    Inventors: Mai Murata, Junichi Minami, Akio Yamada, Tetsuya Kuhara
  • Publication number: 20200338140
    Abstract: Provided is a composition for preventing or improving impaired renal function, containing Bifidobacterium breve as an active ingredient. The composition for preventing or improving impaired renal function is capable of reducing blood creatinine levels. The composition for preventing or improving impaired renal function can also be used in a pharmaceutical composition or a food or beverage product composition.
    Type: Application
    Filed: April 25, 2019
    Publication date: October 29, 2020
    Applicant: MORINAGA MILK INDUSTRY CO., LTD.
    Inventors: Mai Murata, Junichi Minami
  • Publication number: 20200338141
    Abstract: It is an aspect to provide a novel composition for lowering blood uric acid levels and a novel composition for preventing or ameliorating hyperuricemia. A composition for lowering blood uric acid levels comprising Bifidobacterium breve as an active ingredient is provided. A composition for preventing or ameliorating hyperuricemia comprising Bifidobacterium breve as an active ingredient is provided. A composition for lowering blood uric acid levels and a composition for preventing or ameliorating hyperuricemia can be used in a pharmaceutical composition or a food or beverage composition.
    Type: Application
    Filed: April 25, 2019
    Publication date: October 29, 2020
    Applicant: MORINAGA MILK INDUSTRY CO., LTD.
    Inventors: Mai Murata, Junichi Minami
  • Publication number: 20190298783
    Abstract: A composition for relieving stress comprising a Bifidobacterium breve MCC 1274 (FERMBP-11175) as an active ingredient is provided. The composition for relieving stress according to the present technology can improve or prevent stress-induced anger, confusion, tension, or fatigue, or can improve vigor., stress can be assessed by POMS or POMS 2. The composition for relieving stress according to the present technology can be used for pharmaceutical compositions and food and drink compositions.
    Type: Application
    Filed: March 12, 2019
    Publication date: October 3, 2019
    Applicant: MORINAGA MILK INDUSTRY CO., LTD.
    Inventors: Mai Murata, Junichi Minami, Hazuki Maehata
  • Publication number: 20190297909
    Abstract: Provided is a composition for preventing or ameliorating a functional gastrointestinal disorder whose active ingredient is Bifidobacterium breve MCC1274 (FERM BP-11175). A composition for preventing or ameliorating a functional gastrointestinal disorder in the present technology can prevent or improve constipation or frequent bowel movements, regulate the number of bowel movements, improve stool quality, prevent or improve constipation, prevent or ameliorate bloating, or prevent or improve abdominal discomfort. Disclosed is a composition for preventing or ameliorating a functional gastrointestinal disorder accompanied by anxiety disorder. A composition for preventing or ameliorating a functional gastrointestinal disorder in the present technology can be used in a pharmaceutical composition or in a food or beverage composition.
    Type: Application
    Filed: March 12, 2019
    Publication date: October 3, 2019
    Applicant: MORINAGA MILK INDUSTRY CO., LTD.
    Inventors: Mai Murata, Junichi Minami, Hazuki Maehata
  • Publication number: 20150250184
    Abstract: An antimicrobial activity enhancing agent for lactoferrin or a lactoferrin hydrolysate, which contains ribonuclease-4 as an active ingredient, and a method for producing an antimicrobial activity enhancing agent for lactoferrin or a lactoferrin hydrolysate, which comprises (a) the step of contacting raw milk with a cation exchange resin to adsorb proteins in the raw milk to the cation exchange resin, (b) the step of washing the cation exchange resin having undergone the adsorption treatment, and flowing an elution solvent to elute a protein fraction having an isoelectric point of 8.0 to 10.0, and (c) the step of subjecting the eluted protein fraction to gel filtration using a gel filtration carrier to collect a fraction of a molecular weight of 30 kDa or less.
    Type: Application
    Filed: May 21, 2015
    Publication date: September 10, 2015
    Applicant: MORINAGA MILK INDUSTRY CO., LTD.
    Inventors: Mai Murata, Hiroyuki Wakabayashi, Koji Yamauchi
  • Publication number: 20140134704
    Abstract: An antimicrobial activity enhancing agent for lactoferrin or a lactoferrin hydrolysate, which contains ribonuclease-4 as an active ingredient, and a method for producing an antimicrobial activity enhancing agent for lactoferrin or a lactoferrin hydrolysate, which comprises (a) the step of contacting raw milk with a cation exchange resin to adsorb proteins in the raw milk to the cation exchange resin, (b) the step of washing the cation exchange resin having undergone the adsorption treatment, and flowing an elution solvent to elute a protein fraction having an isoelectric point of 8.0 to 10.0, and (c) the step of subjecting the eluted protein fraction to gel filtration using a gel filtration carrier to collect a fraction of a molecular weight of 30 kDa or less.
    Type: Application
    Filed: July 29, 2011
    Publication date: May 15, 2014
    Applicant: MORINAGA MILK INDUSTRY CO., LTD.
    Inventors: Mai Murata, Hiroyuki Wakabayashi, Koji Yamauchi
  • Publication number: 20130129707
    Abstract: An antimicrobial activity enhancing agent for lactoferrin or a lactoferrin hydrolysate, which contains a milk protein as an active ingredient and has the following properties, and a method for producing the antimicrobial activity enhancing agent, which comprises (a) the step of contacting raw milk with a cation exchange resin to adsorb proteins in the raw milk to the cation exchange resin, (b) the step of washing the cation exchange resin having undergone the adsorption treatment, and flowing an elution solvent to elute a protein fraction having an isoelectric point of 9.0 to 11.0, and (c) the step of subjecting the eluted protein fraction to membrane filtration using an ultrafiltration membrane having a molecular weight cutoff of 30 kDa to prepare the milk protein having the following properties: (A) an action of enhancing the antimicrobial activity of lactoferrin or a lactoferrin hydrolysate, (B) a molecular weight of 30 kDa or less, (C) an isoelectric point of 9.0 to 11.0.
    Type: Application
    Filed: July 29, 2011
    Publication date: May 23, 2013
    Applicant: MORINAGA MILK INDUSTRY CO., LTD.
    Inventors: Mai Murata, Hiroyuki Wakabayashi, Koji Yamauchi
  • Patent number: 8420128
    Abstract: An agent for thermally stabilizing lactoferrin, which comprises a nucleic acid as an active ingredient, can be added to lactoferrin to impart thermal stability to lactoferrin. Thermally stabilized lactoferrin can be heat-sterilized at a pH value around a neutral pH value while keeping its activity.
    Type: Grant
    Filed: March 31, 2009
    Date of Patent: April 16, 2013
    Assignee: Morinaga Milk Industry Co., Ltd.
    Inventors: Ayako Horigome, Mai Murata, Koji Yamauchi, Mitsunori Takase, Yasuhiro Takeda, Junichi Hashimoto, Ikumi Kojima
  • Publication number: 20100310673
    Abstract: An agent for thermally stabilizing lactoferrin, which comprises a nucleic acid as an active ingredient, can be added to lactoferrin to impart thermal stability to lactoferrin. Thermally stabilized lactoferrin can be heat-sterilized at a pH value around a neutral pH value while keeping its activity.
    Type: Application
    Filed: March 31, 2009
    Publication date: December 9, 2010
    Applicant: MORINAGA MILK INDUSTRY CO., LTD.
    Inventors: Ayako Horigome, Mai Murata, Koji Yamauchi, Mitsunori Takase, Yasuhiro Takeda, Junichi Hashimoto, Ikumi Kojima